unknown
Stage
1
Investors
About
Crossfire Oncology is a clinical-stage biotechnology company developing novel small molecule therapies for cancer patients. They focus on precision oncology by targeting specific pathways involved in cancer growth and resistance.
Explore Crossfire Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.